Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04634071 · ClinicalTrials.gov registry record · Phase 2
Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment
A Phase 2 study of Smoking Cessation and Cancer, Treatment-Related, sponsored by Joseph Valentino, MD.
- Completed
- Registry status
- Phase 2
- Development phase
- 126
- Enrollment target
- 3
- Study locations
NCT04634071 is a Phase 2 study of Smoking Cessation and Cancer, Treatment-Related that has completed, run by Joseph Valentino, MD. The registered enrollment target is 126 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (73% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT04634071, a Phase 2 study of Smoking Cessation and Cancer, Treatment-Related, has completed, sponsored by Joseph Valentino, MD.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 126 participants
- Enrollment target
- 3
- Study locations
Study Summary
Smoking cessation has been shown to improve the effectiveness and reduce the morbidity of tobacco-related cancer treatments. We will identify effective smoking cessation strategies for patients who are receiving treatment for tobacco-related cancer. In this trial, patients' preferences in smoking cessation therapy will be the principal determinant by providers in developing a three component regimen of pharmaceutical therapy, counseling, and nicotine replacement therapy. This study will identify this cohort's preferences for smoking cessation strategies. We will then examine the impact of utilizing patient preferences upon cessation efficacy by directly comparing cessation success in this study with our recently completed study of the same population using the same tobacco treatments which were randomly assigned.
Conditions Studied
Interventions
- DRUG Varenicline
- DRUG Bupropion
- DRUG Long-acting nicotine replacement therapy
- BEHAVIORAL Low-intensity counseling
- BEHAVIORAL High-intensity counseling
Study Locations (3)
Kentucky
- Med Center Health - Bowling Green
- University Of Kentucky, Markey Cancer Center - Lexington
- Owensboro Health Mitchell Memorial Cancer Center - Owensboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2021-01-12 |
| Est. Completion | 2026-01-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04634071
The ClinicalTrials.gov registry entry for NCT04634071 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (73% lower). The listed sponsor is Joseph Valentino, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 5 interventions - of which Varenicline is the first listed.
NCT04634071 reports 3 study locations spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT04634071 about?
NCT04634071 is a clinical study titled "Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment". Smoking cessation has been shown to improve the effectiveness and reduce the morbidity of tobacco-related cancer treatments. We will identify effective smoking cessation strategies for patients who are receiving treatment for tobacco-related cancer. In this trial, patients' preferences in smoking ce...
What is the current status of trial NCT04634071?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 126 participants. The study started on 2021-01-12. Estimated completion is 2026-01-02.
What conditions does trial NCT04634071 study?
This clinical trial studies the following conditions: Smoking Cessation, Cancer, Treatment-Related.
What interventions are being tested in trial NCT04634071?
The interventions under investigation include: Varenicline (DRUG), Bupropion (DRUG), Long-acting nicotine replacement therapy (DRUG), Low-intensity counseling (BEHAVIORAL), High-intensity counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT04634071?
This trial is sponsored by Joseph Valentino, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04634071 being conducted?
This trial has 3 study locations across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity
RECRUITING · Phase 2
-
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
RECRUITING · Phase 2
-
Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate
COMPLETED · Phase 2
-
Treating Smokers With Mental Illness
COMPLETED · Phase 2
-
Suvorexant to Reduce Symptoms of Nicotine Use
COMPLETED · Phase 2
-
Pharmacogenetics, Emotional Reactivity and Smoking
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.